Contribution: Industrial Research Assistance Program – Contributions to Firms
Modus Medical Devices Inc.
$385,066.00
ITEA - 20052 SIGNET - Sensing and Image-Guided Neurological Therapies, Cardiac Electrophysiology and Tumor treatment
FY 2021-22 · 2022-01-26
Summary
ITEA - 20052 SIGNET led by Philips (Netherlands). As part of the international consortium project “SIGNET”, this project will focus on developing efficient image-guided treatment workflows to replace currently complex procedures in cardiology, oncology and neurology. We develop systems and technologies, AI-enabled products and solutions, necessary to ultimately realize the North Star of single-episode, personalized, dose-adaptive, high-precision Magnetic Resonance guided treatments and interventions. These technologies and solutions aim to improve patient comfort, safety, treatment outcome, staff availability and economic viability. We focus on use cases where alternative image guidance approaches are either not feasible or where the value of direct MR visualization is obvious.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
London|London, Ontario, Canada
Recipient Type
For-profit organization
Business Number
866725245
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2022-01-26 | 2021-22 | $628,500.00 |
| 1 | 2022-01-26 | 2021-22 | $492,040.00 |
| 3 | 2022-01-26 | 2021-22 | $492,040.00 |
| 4 | 2022-01-26 | 2021-22 | $385,066.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is -106,974 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de - 106 974 dollars.
Agreement End Date
2025-01-31
Agreement Number
988577
Agreement Start Date
2022-01-26
Agreement Title
ITEA - 20052 SIGNET - Sensing and Image-Guided Neurological Therapies, Cardiac Electrophysiology and Tumor treatment
Agreement Title (French)
ITEA – 20052 SIGNET – Thérapies neurologiques par détection et guidage par l'image, électrophysiologie cardiaque et traitement des tumeurs.
Agreement Type
Contribution
Agreement Value
$385,066.00
Amendment Date
2025-01-30
Amendment Number
4
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
ITEA - 20052 SIGNET led by Philips (Netherlands). As part of the international consortium project “SIGNET”, this project will focus on developing efficient image-guided treatment workflows to replace currently complex procedures in cardiology, oncology and neurology. We develop systems and technologies, AI-enabled products and solutions, necessary to ultimately realize the North Star of single-episode, personalized, dose-adaptive, high-precision Magnetic Resonance guided treatments and interventions. These technologies and solutions aim to improve patient comfort, safety, treatment outcome, staff availability and economic viability. We focus on use cases where alternative image guidance approaches are either not feasible or where the value of direct MR visualization is obvious.
Description (French)
ITEA – 20052 SIGNET dirigé par Philips (Pays-Bas). Dans le cadre du projet de consortium international "SIGNET", ce projet portera principalement sur la mise au point de flux de traitement efficaces guidés par l'image pour remplacer les procédures complexes utilisées actuellement en cardiologie, en oncologie et en neurologie. Nous créons des systèmes et des technologies, des produits et des solutions basés sur l'intelligence artificielle, nécessaires pour réaliser des traitements et des interventions exemplaires guidés par résonance magnétique en un seul épisode, personnalisés, adaptables à la dose et de haute précision. Ces technologies et solutions visent à améliorer le confort des patients, la sécurité, les résultats des traitements, la disponibilité du personnel et la viabilité économique. Nous nous concentrons sur les cas d'utilisation pour lesquels d'autres approches de guidage par image ne sont pas réalisables ou pour lesquels la valeur de la visualisation directe par RM est évidente.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
London West
Federal Riding (French)
London-Ouest
Federal Riding Number
35053
NAICS Code
339110
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
866725245
Recipient City
London|London
Recipient Country
CA
Recipient Legal Name
Modus Medical Devices Inc.
Recipient Operating Name
Modus QA
Recipient Postal Code
N6H 5L6
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2021-2022-Q4-988577
